Page last updated: 2024-08-23

sulfur and ritonavir

sulfur has been researched along with ritonavir in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amantea, MA; Bu, HZ; Pool, WF; Raber, SR; Shetty, BV; Wu, EY	1
Bu, HZ; Kang, P; Pool, WF; Shetty, BV; Wu, EY; Zhao, P	1
Amantea, MA; Nickens, DJ; Raber, SR; Reynolds, RR; Sarapa, N	1

Trials

2 trial(s) available for sulfur and ritonavir

Article	Year
Metabolism and excretion of capravirine, a new non-nucleoside reverse transcriptase inhibitor, alone and in combination with ritonavir in healthy volunteers. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:7 Topics: Administration, Oral; Anti-HIV Agents; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Feces; Humans; Imidazoles; Male; Reverse Transcriptase Inhibitors; Ritonavir; Spectrometry, Mass, Electrospray Ionization; Sulfur Compounds; Time Factors	2004
Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:1 Topics: Adult; Aza Compounds; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drug Therapy, Combination; Electrocardiography; Female; Fluoroquinolones; Heart Rate; HIV Protease Inhibitors; Humans; Imidazoles; Ketoconazole; Liver; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Reference Values; Reproducibility of Results; Research Design; Reverse Transcriptase Inhibitors; Ritonavir; Sulfur Compounds; Treatment Outcome	2008

Article

Year

Metabolism and excretion of capravirine, a new non-nucleoside reverse transcriptase inhibitor, alone and in combination with ritonavir in healthy volunteers.

Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:7

Topics: Administration, Oral; Anti-HIV Agents; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Feces; Humans; Imidazoles; Male; Reverse Transcriptase Inhibitors; Ritonavir; Spectrometry, Mass, Electrospray Ionization; Sulfur Compounds; Time Factors

2004

Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.

Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:1

Topics: Adult; Aza Compounds; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drug Therapy, Combination; Electrocardiography; Female; Fluoroquinolones; Heart Rate; HIV Protease Inhibitors; Humans; Imidazoles; Ketoconazole; Liver; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Reference Values; Reproducibility of Results; Research Design; Reverse Transcriptase Inhibitors; Ritonavir; Sulfur Compounds; Treatment Outcome

2008

Other Studies

1 other study(ies) available for sulfur and ritonavir

Article	Year
Evaluation of capravirine as a CYP3A probe substrate: in vitro and in vivo metabolism of capravirine in rats and dogs. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:9 Topics: Animals; Anti-HIV Agents; Antibodies, Blocking; Biotransformation; Chromatography, Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Imidazoles; In Vitro Techniques; Male; Mass Spectrometry; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ritonavir; Species Specificity; Substrate Specificity; Sulfur Compounds	2007

Article

Year

Evaluation of capravirine as a CYP3A probe substrate: in vitro and in vivo metabolism of capravirine in rats and dogs.

Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:9

Topics: Animals; Anti-HIV Agents; Antibodies, Blocking; Biotransformation; Chromatography, Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Imidazoles; In Vitro Techniques; Male; Mass Spectrometry; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ritonavir; Species Specificity; Substrate Specificity; Sulfur Compounds

2007